Published in Cancer Lett on November 06, 1995
Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. Br J Pharmacol (2005) 1.19
Anticancer activity of methyl-substituted oxaliplatin analogs. Mol Pharmacol (2012) 0.84
Recent advances in combined modality therapy. Oncologist (2010) 0.81
{(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo. J Med Chem (2010) 0.80
A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol (2013) 0.78
Biological activity of enantiomeric complexes [PtCl(2)L (2)] (L (2) is aromatic bisphosphanes and aromatic diamines). J Biol Inorg Chem (2010) 0.77
The binding assessment with human serum albumin of novel six-coordinate Pt(IV) complexes, containing bidentate nitrogen donor/methyl ligands. Mol Biol Res Commun (2015) 0.75
Oxaliplatin and its enantiomer induce different condensation dynamics of single DNA molecules. PLoS One (2013) 0.75
P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo Approach. PLoS One (2013) 0.75
A fluorimetric study of the hydroxylation of biphenyl in vitro by liver preparations of various species. Biochem J (1965) 2.47
An ERP study of the temporal course of the Stroop color-word interference effect. Neuropsychologia (2000) 2.05
Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother (1992) 1.96
In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother (1986) 1.89
A spectrofluorimetric study of the 7-hydroxylation of coumarin by liver microsomes. Biochem J (1965) 1.76
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine. J Clin Oncol (1998) 1.72
Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. J Med Chem (1996) 1.52
Gangliosides expressed in human breast cancer. Cancer Res (1996) 1.49
Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.48
The fluorescence of some biphenyl derivatives. Biochem J (1965) 1.47
[Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC]. Arq Gastroenterol (1993) 1.40
Origin and phylogeography of the Chagas disease main vector Triatoma infestans based on nuclear rDNA sequences and genome size. Infect Genet Evol (2005) 1.40
Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet (2001) 1.39
In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Cancer Res (1993) 1.37
Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion. Exp Cell Res (1985) 1.32
Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies. Cancer Chemother Rep (1972) 1.32
Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep (1977) 1.29
Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure. Toxicol Appl Pharmacol (1996) 1.25
Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology (1997) 1.25
Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient? Ann Surg Oncol (2001) 1.21
Exclusive Th2 primary effector function in spleens but mixed Th1/Th2 function in lymph nodes of murine neonates. J Immunol (2000) 1.21
Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form. J Med Chem (1978) 1.20
Synthesis and structure-activity relationships of new second-generation taxoids. Bioorg Med Chem Lett (1999) 1.20
Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum. Biomed Pharmacother (1989) 1.19
Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas. Cancer Res (1982) 1.14
Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial. Cancer Epidemiol Biomarkers Prev (1995) 1.12
Isokinetic evaluation of shoulder rotational strength between the plane of scapula and the frontal plane. Am J Sports Med (1990) 1.12
Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients. Urology (1998) 1.11
Soil diversity and hydration as observed by ChemCam at Gale crater, Mars. Science (2013) 1.10
Concomitant elevations in serum sialytransferase activity and sialic acid content in rats with metastasizing mammary tumors. Science (1977) 1.10
Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III. J Med Chem (1997) 1.09
The stimulation of hydroxylation by carcinogenic and non-carcinogenic compounds. Biochem Pharmacol (1966) 1.09
Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies. Br J Cancer (2009) 1.09
Metabolism of tyramine-1-14C by the rat. Biochem Pharmacol (1970) 1.09
Constitutive expression of MHC and adhesion molecules by alveolar epithelial cells (type II pneumocytes) isolated from human lung and comparison with immunocytochemical findings. J Cell Sci (1994) 1.08
Sylvatic population of Triatoma infestans from the Bolivian Chaco: from field collection to characterization. Mem Inst Oswaldo Cruz (2000) 1.07
Appendicolith revealed on CT in children with suspected appendicitis: how specific is it in the diagnosis of appendicitis? AJR Am J Roentgenol (2000) 1.07
Correlates and changes over time in drug and alcohol use within a barrio population. Am J Community Psychol (1980) 1.07
A comparative study of laparoscopy and colpotomy for the removal of ovarian dermoid cysts. Obstet Gynecol (1996) 1.04
A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP). Biomed Pharmacother (1986) 1.04
Susceptibility of Rickettsia conorii and R. rickettsii to pefloxacin, in vitro and in ovo. J Antimicrob Chemother (1987) 1.04
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer (1997) 1.04
Liver scanning and liver function in cystic fibrosis. Acta Paediatr Scand (1972) 1.03
Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood (1979) 1.03
Ethanol oxidation in the microsomal fraction of rat liver. Biochem Biophys Res Commun (1969) 1.02
Syntheses and biological activity of C-3'-difluoromethyl-taxoids. Bioorg Med Chem (2000) 1.00
Glycosidases in cancer and invasion. Cancer Metastasis Rev (1985) 1.00
Dorzolamide effect on ocular blood flow. Invest Ophthalmol Vis Sci (1999) 1.00
Ultrastructural evidence for ectoglycosyltransferase systems. Nature (1975) 1.00
Equivalent renal allograft function with laparoscopic versus open liver donor nephrectomies. Transplant Proc (1999) 1.00
Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res (1993) 0.99
Studies on the human pharmacokinetics of isophosphamide (NSC-109724). Cancer Treat Rep (1976) 0.98
Growth of cell colonies in soft agar from biopsies of different human solid tumors. Cancer Res (1980) 0.98
Structure and stability of semiconductor tip apexes for atomic force microscopy. Nanotechnology (2009) 0.98
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Invest New Drugs (1999) 0.98
Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724). Cancer Treat Rep (1976) 0.98
Genetic variability and geographic differentiation among three species of Triatomine bugs (Hemiptera-Reduviidae). Am J Trop Med Hyg (1997) 0.97
Karyotype evolution in holocentric chromosomes of three related species of triatomines (Hemiptera-Reduviidae). Chromosome Res (1995) 0.96
New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells. Bioorg Med Chem Lett (1998) 0.96
Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res (1993) 0.96
Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 4- and 6-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses. Carbohydr Res (1990) 0.96
Pharmacokinetics of divided-dose ifosfamide. Clin Pharmacol Ther (1976) 0.96
Colony growth in soft agar of human melanoma, sarcoma, and lung carcinoma cells disaggregated by mechanical and enzymatic methods. Cancer Res (1980) 0.96
Biochemical characteristics, metabolism, and antitumor activity of several acetylated hexosamines. J Supramol Struct (1977) 0.95
Characterization of cells obtained by mechanical and enzymatic means from human melanoma, sarcoma, and lung tumors. Cancer Res (1981) 0.95
Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res (1984) 0.95
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Intern Med J (2014) 0.94
Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. J Natl Cancer Inst (2001) 0.94
A new monoclonal antibody for detection of EGF-receptors in western blots and paraffin-embedded tissue sections. J Cell Biochem (1992) 0.94
Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells. Cancer Lett (1996) 0.94
Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Res (1997) 0.94
Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data. Biomed Pharmacother (1989) 0.93
Role of galaptin in ovarian carcinoma adhesion to extracellular matrix in vitro. J Cell Biochem (1990) 0.92
Coordination chemical studies on metalloenzymes. II. Kinetic behavior of various types of chelating agents towards bovine carbonic anhydrase. J Biochem (1977) 0.92
Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs. J Biol Chem (1994) 0.92
Mucin dynamics and microbial populations in chicken small intestine are changed by dietary probiotic and antibiotic growth promoter supplementation. J Nutr (2005) 0.92
Synthesis and structure-activity relationships of nonaromatic taxoids: effects of alkyl and alkenyl ester groups on cytotoxicity. J Med Chem (1997) 0.91
The clinical pharmacology of VM26 and VP16-213. A brief overview. Cancer Chemother Pharmacol (1982) 0.91
Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma. J Clin Oncol (1988) 0.91
Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP). Cancer Treat Rep (1983) 0.91
Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy. Ann Oncol (2003) 0.91
Sacral plexus injury after radiotherapy for carcinoma of cervix. Cancer (1990) 0.91
Antitumor activity of platinum(II) complexes of 1,2-diamino-cyclohexane isomers. Gan (1980) 0.91
Antibacterial properties of eight dental cements. Int Endod J (1993) 0.90
Targeting 5'-deoxy-5'-(methylthio)adenosine phosphorylase by 5'-haloalkyl analogues of 5'-deoxy-5'-(methylthio)adenosine. J Med Chem (1991) 0.90
[Scintigraphy of the choroid plexus (choroid plexography)]. Nouv Presse Med (1975) 0.90
Location of neurons projecting to the retina in mammals. Neurosci Res (1990) 0.90
Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model. Breast Cancer Res Treat (2009) 0.90
Inhibition of herpes simplex virus type 1 penetration by cytochalasins B and D. J Gen Virol (1985) 0.89
Synthesis and biological activity of some 1-N-substituted 2-acetamido-2-deoxy-beta-D-glycopyranosylamine derivatives and related analogs. Carbohydr Res (1980) 0.89
Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity. Cancer Chemother Rep (1972) 0.89
In vitro degradation of extracellular matrix by human ovarian carcinoma cells. Clin Exp Metastasis (1987) 0.89
Neural mechanisms underlying stereoscopic vision. Prog Neurobiol (1998) 0.89
Plasma response of children to short-term chronic beta-carotene supplementation. Am J Clin Nutr (1994) 0.89
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancy. Invest New Drugs (1997) 0.89
Indocyanine green angiography in isolated primary retinal arterial macroaneurysms. Acta Ophthalmol Scand (1998) 0.88
Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia. Cancer Res (1983) 0.88
Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s). Br J Cancer (1997) 0.88